- Home
- ALLR vs CYTO Comparison
ALLR vs CYTO Comparison
Compare ALLR & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- CYTO
- Stock Information
- Founded
- ALLR 2004
- CYTO 2003
- Country
- ALLR United States
- CYTO Bermuda
- Employees
- ALLR N/A
- CYTO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- CYTO Health Care
- Exchange
- ALLR Nasdaq
- CYTO Nasdaq
- Market Cap
- ALLR 2.3M
- CYTO 2.2M
- IPO Year
- ALLR N/A
- CYTO N/A
- Fundamental
- Price
- ALLR $1.32
- CYTO $0.46
- Analyst Decision
- ALLR
- CYTO
- Analyst Count
- ALLR 0
- CYTO 0
- Target Price
- ALLR N/A
- CYTO N/A
- AVG Volume (30 Days)
- ALLR 658.4K
- CYTO 106.0K
- Earning Date
- ALLR 11-14-2024
- CYTO 09-24-2024
- Dividend Yield
- ALLR N/A
- CYTO N/A
- EPS Growth
- ALLR N/A
- CYTO N/A
- EPS
- ALLR N/A
- CYTO N/A
- Revenue
- ALLR N/A
- CYTO N/A
- Revenue This Year
- ALLR N/A
- CYTO N/A
- Revenue Next Year
- ALLR N/A
- CYTO N/A
- P/E Ratio
- ALLR N/A
- CYTO N/A
- Revenue Growth
- ALLR N/A
- CYTO N/A
- 52 Week Low
- ALLR $1.26
- CYTO $0.40
- 52 Week High
- ALLR $666.00
- CYTO $17.20
- Technical
- Relative Strength Index (RSI)
- ALLR 32.39
- CYTO 35.16
- Support Level
- ALLR $1.32
- CYTO $0.40
- Resistance Level
- ALLR $1.53
- CYTO $0.62
- Average True Range (ATR)
- ALLR 0.12
- CYTO 0.06
- MACD
- ALLR 0.05
- CYTO 0.00
- Stochastic Oscillator
- ALLR 14.63
- CYTO 25.18
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.